Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

New treatments for PCOS focus on managing symptoms and improving fertility.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Spironolactone works well for acne and hirsutism, isotretinoin is very effective for acne and may have antiandrogenic effects, and 5 alpha-reductase inhibitors should be considered antiandrogens.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Some acne medications have side effects; doctors should educate patients and may not need to do frequent lab tests for all.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.